Avadel Pharmaceuticals Plc Stock Analysis

Avadel Stock Analysis Notes

About 80.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.07. Avadel Pharmaceuticals recorded a loss per share of 1.09. The entity had not issued any dividends in recent years. Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland. Avadel Pharmaceuticals is traded on NASDAQ Exchange in the United States. For more info on Avadel Pharmaceuticals PLC please contact the company at 353 1 901 5201 or go to https://www.avadel.com.

Avadel Pharmaceuticals Investment Alerts

Avadel Pharmaceuticals Upcoming and Recent Events

Avadel Largest EPS Surprises

View All Earnings Estimates

Avadel Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Avadel Stock Institutional Investors

Note, although Avadel Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Avadel Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 1.27 B.

Avadel Profitablity

The company has Profit Margin (PM) of (1.12) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.31) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.31.

Management Efficiency

Avadel Pharmaceuticals has return on total asset (ROA) of (0.3445) % which means that it has lost $0.3445 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.9952) %, meaning that it created substantial loss on money invested by shareholders. Avadel Pharmaceuticals' management efficiency ratios could be used to measure how well Avadel Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is expected to rise to -1.03 this year. Return On Capital Employed is expected to rise to -1.02 this year. At this time, Avadel Pharmaceuticals' Non Current Assets Total are quite stable compared to the past year. Fixed Asset Turnover is expected to rise to 8.17 this year, although the value of Total Assets will most likely fall to about 134.2 M.

Technical Drivers

As of the 26th of November, Avadel Pharmaceuticals shows the risk adjusted performance of (0.06), and Mean Deviation of 2.42. Avadel Pharmaceuticals technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Avadel Pharmaceuticals standard deviation, as well as the relationship between the maximum drawdown and kurtosis to decide if Avadel Pharmaceuticals is priced correctly, providing market reflects its regular price of 11.22 per share. Given that Avadel Pharmaceuticals has information ratio of (0.12), we suggest you to validate Avadel Pharmaceuticals PLC's prevailing market performance to make sure the company can sustain itself at a future point.

Avadel Pharmaceuticals Price Movement Analysis

Avadel Pharmaceuticals Insider Trading Activities

Avadel Pharmaceuticals Outstanding Bonds

Avadel Pharmaceuticals Predictive Daily Indicators

Avadel Pharmaceuticals Corporate Filings

Avadel Pharmaceuticals Forecast Models

Avadel Pharmaceuticals' time-series forecasting models are one of many Avadel Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Avadel Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Avadel Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Avadel shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Avadel Pharmaceuticals. By using and applying Avadel Stock analysis, traders can create a robust methodology for identifying Avadel entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Avadel analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Avadel analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Avadel Pharmaceuticals PLC stock analysis indicators help investors evaluate how Avadel Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Avadel Pharmaceuticals shares will generate the highest return on investment. By understating and applying Avadel Pharmaceuticals stock analysis, traders can identify Avadel Pharmaceuticals position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.